The association between vitamin D and C-reactive protein levels in patients with inflammatory and non-inflammatory diseases

Clinical Biochemistry

Volumn 49, Issue 7-8, 2016, Pages 534-537

  Kruit, Adrian ^a   Zanen, Pieter ^b  

^a NIJ SMELLINGHE HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

25(OH) vitamin D; C reactive protein; Inflammation

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; C REACTIVE PROTEIN; 25-HYDROXYVITAMIN D; VITAMIN D;

AGED; ANALYSIS OF VARIANCE; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENDER; HOSPITAL PATIENT; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; NONINFLAMMATORY DISEASE; OUTPATIENT; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEASON; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; FOLLOW UP; IMMUNOLOGICAL PROCEDURES; INFLAMMATION; PROGNOSIS; RISK FACTOR; VITAMIN D DEFICIENCY;

AGED; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC TESTS; INFLAMMATION; MALE; PROGNOSIS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84954285210     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2016.01.002     Document Type: Article

References (33)

1. Albert P.J., Proal A.D., Marshall T.G. Vitamin D: the alternative hypothesis. Autoimmun. Rev. 2009, 8:639-644.
2. Baeke F., Takiishi T., Korf H., Gysemans C., Mathieu C. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 2010, 10:482-496.
3. Lin Z., Li W. The roles of vitamin D and its analogs in inflammatory diseases. Curr. Top. Med. Chem. 2015.
4. Zakeri Z., M S., MA M., V R., S S. Serum vitamin D level and disease activity in patients with recent onset rheumatoid arthritis. Int. J. Rheum. Dis. 2013.
5. Patel S., Farragher T., Berry J., Bunn D., Silman A., Symmons D. Association between serum vitamin d metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 2007, 56:2143-2149.
6. Torki M., Gholamrezaei A., Mirbagher L., Danesh M., Kheiri S., Emami M.H. Vitamin D deficiency associated with disease activity in patients with inflammatory bowel diseases. Dig. Dis. Sci. 2015, 60:3085-3091.
7. Murr C., Pilz S., Grammer T.B., Kleber M.E., Meinitzer A., Boehm B.O., et al. Vitamin D deficiency parallels inflammation and immune activation, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin. Chem. Lab. Med. 2012, 50:2205-2212.
8. Devaraj S., Jialal G., Cook T., Siegel D., Jialal I. Low vitamin D levels in northern American adults with the metabolic syndrome. Horm. Metab. Res. 2011, 43:72-74.
9. Devaraj S., Yun J.M., Duncan-Staley C.R., Jialal I. Low vitamin D levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications. Am. J. Clin. Pathol. 2011, 135:429-433.
10. Amer M., Qayyum R. Relation between serum 25-hydroxyvitamin d and c-reactive protein in asymptomatic adults (from the continuous national health and nutrition examination survey 2001 to 2006). Am. J. Cardiol. 2012, 109:226-230.
11. Ghashut R.A., Talwar D., Kinsella J., Duncan A., McMillan D.C. The effect of the systemic inflammatory response on plasma vitamin 25 (oh) d concentrations adjusted for albumin. PLoS ONE 2014, 9.
12. Laird E., McNulty H., Ward M., Hoey L., McSorley E., Wallace J.M., et al. Vitamin d deficiency is associated with inflammation in older Irish adults. J. Clin. Endocrinol. Metab. 2014, 99:1807-1815.
13. Mellenthin L., Wallaschofski H., Grotevendt A., Volzke H., Nauck M., Hannemann A. Association between serum vitamin D concentrations and inflammatory markers in the general adult population. Metab. Clin. Exp. 2014, 63:1056-1062.
14. Hypponen E., Berry D., Cortina-Borja M., Power C. 25-hydroxyvitamin d and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British birth cohort. PLoS ONE 2010, 5.
15. Amrein K., Zajic P., Schnedl C., Waltensdorfer A., Fruhwald S., Holl A., et al. Vitamin D status and its association with season, hospital and sepsis mortality in critical illness. Crit. Care 2014, 18:R47.
16. Grzanka A., Machura E., Mazur B., Misiolek M., Jochem J., Kasperski J., et al. Relationship between vitamin D status and the inflammatory state in patients with chronic spontaneous urticaria. J. Inflamm. 2014, 11:2.
17. Chen N., Wan Z., Han S.F., Li B.Y., Zhang Z.L., Qin L.Q. Effect of vitamin D supplementation on the level of circulating high-sensitivity c-reactive protein: a meta-analysis of randomized controlled trials. Nutrients 2014, 6:2206-2216.
18. Jorde R., Sneve M., Torjesen P.A., Figenschau Y., Goransson L.G., Omdal R. No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 2010, 50:175-180.
19. Barnes M.S., Horigan G., Cashman K.D., Hill T.R., Forsythe L.K., Lucey A.J., et al. Maintenance of wintertime vitamin D status with cholecalciferol supplementation is not associated with alterations in serum cytokine concentrations among apparently healthy younger or older adults. J. Nutr. 2011, 141:476-481.
20. Carlson N., Mah R., Aburto M., Peters M.J., Dupper M.V., Chen L.H. Hypovitaminosis D correction and high-sensitivity c-reactive protein levels in hypertensive adults. Perm. J. 2013, 17:19-21.
21. Zanetti M., Harris S.S., Dawson-Hughes B. Ability of vitamin D to reduce inflammation in adults without acute illness. Nutr. Rev. 2014, 72:95-98.
22. Grzanka A., Damasiewicz-Bodzek A., Machura E., Szumska M., Tyrpien-Golder K., Mazur B., et al. Chronic spontaneous urticaria is characterized by lower serum advanced glycation end-products. Biomed. Res. Int. 2014, 2014:974154.
23. Reid D., Toole B.J., Knox S., Talwar D., Harten J., O'Reilly D.S., et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin d concentrations after elective knee arthroplasty. Am. J. Clin. Nutr. 2011, 93:1006-1011.
24. Waldron J.L., Ashby H.L., Cornes M.P., Bechervaise J., Razavi C., Thomas O.L., et al. Vitamin D: a negative acute phase reactant. J. Clin. Pathol. 2013, 66:620-622.
25. Newens K., Filteau S., Tomkins A. Plasma 25-hydroxyvitamin D does not vary over the course of a malarial infection. Trans. R. Soc. Trop. Med. Hyg. 2006, 100:41-44.
26. Barth J.H., Field H.P., Mather A.N., Plein S. Serum 25 hydroxy-vitamin D does not exhibit an acute phase reaction after acute myocardial infarction. Ann. Clin. Biochem. 2012, 49:399-401.
27. Silva M.C., Furlanetto T.W. Does serum 25-hydroxyvitamin d decrease during acute-phase response? A systematic review. Nutr. Res. 2015, 35:91-96.
28. Stamp T.C., Round J.M. Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature 1974, 247:563-565.
29. Ginde A.A., Mansbach J.M., Camargo C.A. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the third national health and nutrition examination survey. Arch. Intern. Med. 2009, 169:384-390.
30. Ponsonby A.L., McMichael A., van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 2002, 181-182:71-78.
31. Staples J.A., Ponsonby A.L., Lim L.L., McMichael A.J. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ. Health Perspect. 2003, 111:518-523.
32. Shea M.K., Booth S.L., Massaro J.M., Jacques P.F., D'Agostino R.B., Dawson-Hughes B., et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am. J. Epidemiol. 2008, 167:313-320.
33. Woods J.A., Wilund K.R., Martin S.A., Kistler B.M. Exercise, inflammation and aging. Aging Dis. 2012, 3:130-140.